Everest Medicines Ltd SEC EDGAR Filings (CIK 0001783937)

SEC EDGAR filings, ownership reports, and insider transactions for Everest Medicines Ltd.

Business address
Suite 6601 6606, Plaza 66, Tower 1, 1266 West Nanjing Road, Shanghai
Top holdings (Schedule 13D)
IMAB
State of incorporation
Cayman Islands
Fiscal year end
31 December
Everest Medicines Ltd has filed 2 SEC EDGAR filings since 10 Oct 2023

Latest Filings

Recent SEC filings for Everest Medicines Ltd including SCHEDULE 13D, 144.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 05 Aug 2025
144 Open 144 document View SEC filing for 144 10 Oct 2023

About this filer

Everest Medicines Ltd files with the SEC under CIK 0001783937. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages